Atherosclerosis: cell biology and lipoproteins

Area of Science:

• Cardiovascular Science
• Biochemistry
• Immunology

Background:

• Lipoproteins play a dual role in atherosclerosis, promoting or preventing its development.
• Recent research investigates the intricate composition and function of HDL and its subclasses.
• The role of apolipoprotein C-III (apoC-III) in lipoprotein metabolism and cardiovascular risk is a key area of study.

Purpose of the Study:

• To review recent findings on HDL subclasses, apoC-III in lipoprotein metabolism, Lipoprotein (a) (Lp(a)) effects on endothelial cells, and LDL uptake mechanisms.
• To elucidate the complex relationship between HDL composition, function, and cholesterol efflux capacity.
• To examine the impact of apoC-III on triglyceride-rich lipoprotein clearance and cardiovascular risk, particularly in diabetics.

Main Methods:

• Analysis of protein and lipid content in murine and human HDL.
• Investigation of apoC-III's role in lipoprotein lipase (LPL) activity and clearance.
• Assessment of Lp(a)'s effect on endothelial cell inflammatory and glycolytic responses.
• Exploration of Toll-like receptor 4 (TLR4) involvement in aggregated LDL uptake.

Main Results:

• HDL exhibits both antiatherogenic and proatherogenic properties.
• apoC-III influences triglyceride-rich lipoprotein metabolism and is linked to increased cardiovascular risk in type 1 diabetics.
• Oxidized phospholipids in Lp(a) induce inflammatory and glycolytic responses in endothelial cells.
• TLR4 mediates the uptake of aggregated LDL, contributing to foam cell formation.

Conclusions:

• These findings enhance the mechanistic understanding of lipoprotein involvement in atherogenesis.
• The studies identify potential therapeutic targets for managing atherosclerosis.
• Further research into lipoprotein subclasses and their cellular interactions is crucial for developing novel treatments.